Insider · CIK 0001710863
Douglas J. Hughes
Files at IMVT (Immunovant, Inc.). First filing Dec 4, 2024, latest Dec 3, 2025.
Douglas J. Hughes files SEC Form 4 as director at IMVT (Immunovant, Inc.). Since Dec 4, 2024, Douglas J. Hughes has reported 0 open-market buys worth $0 and 2 open-market sells worth $503k, the latest filed on Dec 3, 2025.
A track record needs three past buys with six months of prices behind them; Douglas J. Hughes has 0, so none is measured yet.
The newest scored trade: sold $349k of IMVT on Dec 1, 2025, filed Dec 3, 2025, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $349k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Immunovant, Inc. | $349k 15,000 shares | -11% | +71% from low-21% from high | |
| 21Weak | Immunovant, Inc. | $155k 5,425 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 1, 2025 | IMVT IMMUNOVANT, INC. | 15,000 0.01% of outstanding | $362k | Dec 1, 2025 | none |
| Dec 2, 2024 | IMVT IMMUNOVANT, INC. | 5,425 0.00% of outstanding | $153k | Dec 2, 2024 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +13,880 | $0.00 | $0 | 134,653 | Apr 9, 2026 |
| Apr 7, 2026 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,061 | $0.00 | $0 | 7,061 | Apr 9, 2026 |
| Dec 1, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -13,091 | $23.14 | $303k | 122,682 | Dec 3, 2025 |
| Dec 1, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -1,909 | $23.96 | $46k | 120,773 | Dec 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +16,188 | $0.00 | $0 | 135,773 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,600 | $0.00 | $0 | 7,600 | Apr 3, 2025 |
| Dec 2, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -5,425 | $28.54 | $155k | 119,585 | Dec 4, 2024 |
Questions about Douglas J. Hughes
Answered from the filings on this page, as of the latest one.
Is Douglas J. Hughes buying or selling?
In the last 12 months Douglas J. Hughes reported 0 open-market buys worth $0 and 1 open-market sell worth $349k on SEC Form 4; the latest was sold $349k of IMVT on Dec 1, 2025. Grants, option exercises and tax withholding are not counted.
How did Douglas J. Hughes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas J. Hughes has 0.
Where does Douglas J. Hughes file Form 4?
Douglas J. Hughes has filed Form 4 at IMVT (Immunovant, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.